Dermal Filler Injections Mimic Tumor Activity during Immune Checkpoint Inhibition

Respiration. 2018;95(5):362-363. doi: 10.1159/000487601. Epub 2018 Apr 5.

Authors

Zulfiya Syunyaeva^{1

2}, Kathrin Kahnert^{1

2}, Diego Kauffmann-Guerrero^{1

2}, Rudolf Maria Huber^{1

2}, Amanda Tufman^{1

2}

Affiliations

¹ Division of Respiratory Medicine and Thoracic Oncology, Department of Internal Medicine V, University of Munich (LMU), Thoracic Oncology Centre Munich, Munich, Germany.
² Comprehensive Pneumology Center, Member of the German Center for Lung Research (DZL), Munich, Germany.

PMID: 29621778
DOI: 10.1159/000487601

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal / adverse effects*
Antineoplastic Agents / adverse effects*
Carcinoma, Non-Small-Cell Lung / drug therapy
Dermal Fillers / adverse effects*
Female
Foreign-Body Reaction / chemically induced*
Humans
Immunotherapy / adverse effects*
Lung Neoplasms / drug therapy
Middle Aged
Nivolumab

Substances

Antibodies, Monoclonal
Antineoplastic Agents
Dermal Fillers
Nivolumab